5th St., Suite 800 Austin, TX 78701, US Get directions 5000 Meridian Blvd Franklin, Tennessee 37067, US Employees at First Trust Updates The latest Cash Flow and Carey blog post dives into Growth vs
Key differences between cagrilintide and semaglutide Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways, complementary effects Gastric emptying: Cagrilintide: Very strong effect (dramatic slowing) Semaglutide: Moderate effect Combined: Maximum slowing Appetite suppression: Cagrilintide: Works via amylin/calcitonin receptors Semaglutide: Works via GLP-1 receptors in brain Combined: Dual-pathway suppression Side effects: Cagrilintide: More nausea/GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Combined: Higher side effect risk but manageable Approval status: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved CagriSema combination: Phase 3 trials Weight loss monotherapy: Cagrilintide alone: 10-12% body weight loss Semaglutide alone: 10-15% body weight loss Combined: 15-25% body weight loss Why combining cagrilintide and semaglutide works synergistically The combination targets weight loss through multiple pathways
Hydrating before, during, and after these activities will help you stay energized and prevent heat-related illnesses
If you are considering GLP-1 therapy for weight loss, we offer a free initial consultation to see if our program is right for you.
Common Side Effects Injection-site reactions: Mild redness, tenderness or soreness can occur
